阻滞剂-话题@MedSci

#阻滞剂#

205篇内容 | 4065人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2085715, encodeId=84ae2085e15fb, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=BMJ:β受体阻滞剂可减少COPD的急性发作, objectType=article, longId=55494, objectId=b3d655494a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3d655494a6, replyNumber=0, likeNumber=68, createdTime=2016-06-21, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3d655494a6, moduleTitle=BMJ:β受体阻滞剂可减少COPD的急性发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3d655494a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085714, encodeId=6d782085e147f, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=World J Surg：闭合性创伤性脑损伤后，β受体阻滞剂对生存率的影响, objectType=article, longId=54975, objectId=02df549e5eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02df549e5eb, replyNumber=0, likeNumber=70, createdTime=2016-08-01, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02df549e5eb, moduleTitle=World J Surg：闭合性创伤性脑损伤后，β受体阻滞剂对生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02df549e5eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085717, encodeId=f6172085e173f, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA Intern Med：使用β受体阻滞剂降压治疗风险大, objectType=article, longId=57029, objectId=deca5e0298e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deca5e0298e, replyNumber=0, likeNumber=58, createdTime=2015-12-02, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deca5e0298e, moduleTitle=JAMA Intern Med：使用β受体阻滞剂降压治疗风险大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deca5e0298e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085710, encodeId=89ff2085e10eb, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？, objectType=article, longId=49414, objectId=79a64941446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79a64941446, replyNumber=0, likeNumber=60, createdTime=2016-01-26, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79a64941446, moduleTitle=SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79a64941446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085724, encodeId=761e2085e247f, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Chest：治疗脓毒症期间房颤——β受体阻滞剂优于CCBs, objectType=article, longId=61921, objectId=f1336192167, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1336192167, replyNumber=0, likeNumber=137, createdTime=2016-10-28, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1336192167, moduleTitle=Chest：治疗脓毒症期间房颤——β受体阻滞剂优于CCBs, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1336192167)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085716, encodeId=a2c32085e16ab, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响, objectType=article, longId=56459, objectId=e57356459ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e57356459ae, replyNumber=0, likeNumber=76, createdTime=2015-11-13, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e57356459ae, moduleTitle=JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e57356459ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085707, encodeId=08b22085e07bc, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=CCQO：β受体阻滞剂对冠心病患者没有明显临床疗效, objectType=article, longId=41026, objectId=d9824102628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9824102628, replyNumber=0, likeNumber=54, createdTime=2015-04-22, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9824102628, moduleTitle=CCQO：β受体阻滞剂对冠心病患者没有明显临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9824102628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085712, encodeId=f2ad2085e122c, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=BJA：β-受体阻滞剂对腹主动脉瘤病人体能的影响, objectType=article, longId=53087, objectId=f9315308ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9315308ecd, replyNumber=0, likeNumber=50, createdTime=2016-04-15, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9315308ecd, moduleTitle=BJA：β-受体阻滞剂对腹主动脉瘤病人体能的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9315308ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085706, encodeId=43e72085e064a, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=ESC 2014：射血分数保留的AMI患者长期用β阻滞剂无益？（FAST-MI 2005）, objectType=article, longId=39843, objectId=6658398436e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6658398436e, replyNumber=0, likeNumber=71, createdTime=2015-05-15, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6658398436e, moduleTitle=ESC 2014：射血分数保留的AMI患者长期用β阻滞剂无益？（FAST-MI 2005）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6658398436e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085709, encodeId=13712085e09f5, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JASN：高透析率β阻滞剂或增透析者死亡风险, objectType=article, longId=42189, objectId=42da42189ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42da42189ac, replyNumber=0, likeNumber=59, createdTime=2015-02-23, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42da42189ac, moduleTitle=JASN：高透析率β阻滞剂或增透析者死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42da42189ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085701, encodeId=365e2085e011f, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Gastroenterology：非选择性β受体阻滞剂可能增加自发性细菌性腹膜炎的肝硬化患者的死亡风险, objectType=article, longId=36147, objectId=74c73614e97, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74c73614e97, replyNumber=0, likeNumber=79, createdTime=2015-05-11, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74c73614e97, moduleTitle=Gastroenterology：非选择性β受体阻滞剂可能增加自发性细菌性腹膜炎的肝硬化患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74c73614e97)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085700, encodeId=68da2085e001d, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=ACC 2014：早期静脉用β阻滞剂或可减少STEMI患者梗死面积, objectType=article, longId=32931, objectId=955232931f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=955232931f1, replyNumber=0, likeNumber=71, createdTime=2014-07-27, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=955232931f1, moduleTitle=ACC 2014：早期静脉用β阻滞剂或可减少STEMI患者梗死面积, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=955232931f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085708, encodeId=e8882085e0868, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=β阻滞剂不能使无心梗病史的冠心病患者获益（CHARISMA试验）, objectType=article, longId=41256, objectId=60354125644, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60354125644, replyNumber=0, likeNumber=80, createdTime=2014-10-20, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60354125644, moduleTitle=β阻滞剂不能使无心梗病史的冠心病患者获益（CHARISMA试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60354125644)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085704, encodeId=30392085e04a8, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA Dermatol：高血压、长期用β阻滞剂或增银屑病风险, objectType=article, longId=37685, objectId=173d3e6857f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=173d3e6857f, replyNumber=0, likeNumber=97, createdTime=2014-08-14, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=173d3e6857f, moduleTitle=JAMA Dermatol：高血压、长期用β阻滞剂或增银屑病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=173d3e6857f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085703, encodeId=37862085e03da, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA Inter Med：研究质疑心脏搭桥手术前使用β受体阻滞剂的作用, objectType=article, longId=36573, objectId=5ddf365e3ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ddf365e3ff, replyNumber=0, likeNumber=54, createdTime=2014-12-19, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ddf365e3ff, moduleTitle=JAMA Inter Med：研究质疑心脏搭桥手术前使用β受体阻滞剂的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ddf365e3ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085705, encodeId=7dd12085e0563, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=郭艺芳：β受体阻滞剂不会走下神坛, objectType=article, longId=37838, objectId=821e3e838ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=821e3e838ef, replyNumber=0, likeNumber=123, createdTime=2014-09-01, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=821e3e838ef, moduleTitle=郭艺芳：β受体阻滞剂不会走下神坛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=821e3e838ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085699, encodeId=4676208569960, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Lancet：欧洲心脏病学会β受体阻滞剂使用推荐受挑战, objectType=article, longId=31306, objectId=f9ea3130654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ea3130654, replyNumber=0, likeNumber=0, createdTime=2014-04-16, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ea3130654, moduleTitle=Lancet：欧洲心脏病学会β受体阻滞剂使用推荐受挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9ea3130654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085702, encodeId=d8922085e023c, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JACC述评：β阻滞剂的不老神话, objectType=article, longId=36291, objectId=a4033629152, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4033629152, replyNumber=0, likeNumber=92, createdTime=2014-10-03, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4033629152, moduleTitle=JACC述评：β阻滞剂的不老神话, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4033629152)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085693, encodeId=4082208569360, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Heart：β阻滞剂和联用他汀改善急性心梗远期生存率更佳, objectType=article, longId=22368, objectId=c418223683b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c418223683b, replyNumber=0, likeNumber=0, createdTime=2014-03-10, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c418223683b, moduleTitle=Heart：β阻滞剂和联用他汀改善急性心梗远期生存率更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c418223683b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085698, encodeId=c5fc208569849, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=孙宁玲：如何看待“JNC 8”对β受体阻滞剂的不同意见？, objectType=article, longId=28804, objectId=48aa2880427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48aa2880427, replyNumber=0, likeNumber=71, createdTime=2014-03-31, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48aa2880427, moduleTitle=孙宁玲：如何看待“JNC 8”对β受体阻滞剂的不同意见？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48aa2880427)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阻滞剂

2020-05-29

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

BMJ:β受体阻滞剂可减少COPD的急性发作

2016-06-21

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

World J Surg：闭合性创伤性脑损伤后，β受体阻滞剂对生存率的影响

2016-08-01

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA Intern Med：使用β受体阻滞剂降压治疗风险大

2015-12-02

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？

2016-01-26

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Chest：治疗脓毒症期间房颤——β受体阻滞剂优于CCBs

2016-10-28

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响

2015-11-13

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

CCQO：β受体阻滞剂对冠心病患者没有明显临床疗效

2015-04-22

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

BJA：β-受体阻滞剂对腹主动脉瘤病人体能的影响

2016-04-15

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

ESC 2014：射血分数保留的AMI患者长期用β阻滞剂无益？（FAST-MI 2005）

2015-05-15

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JASN：高透析率β阻滞剂或增透析者死亡风险

2015-02-23

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Gastroenterology：非选择性β受体阻滞剂可能增加自发性细菌性腹膜炎的肝硬化患者的死亡风险

2015-05-11

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

ACC 2014：早期静脉用β阻滞剂或可减少STEMI患者梗死面积

2014-07-27

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

β阻滞剂不能使无心梗病史的冠心病患者获益（CHARISMA试验）

2014-10-20

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA Dermatol：高血压、长期用β阻滞剂或增银屑病风险

2014-08-14

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA Inter Med：研究质疑心脏搭桥手术前使用β受体阻滞剂的作用

2014-12-19

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

郭艺芳：β受体阻滞剂不会走下神坛

2014-09-01

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Lancet：欧洲心脏病学会β受体阻滞剂使用推荐受挑战

2014-04-16

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JACC述评：β阻滞剂的不老神话

2014-10-03

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Heart：β阻滞剂和联用他汀改善急性心梗远期生存率更佳

2014-03-10

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

孙宁玲：如何看待“JNC 8”对β受体阻滞剂的不同意见？

2014-03-31

科室
- - 订阅+
  - 更多科室
工具
服务